Identification of novel pretranslational regulatory mechanisms for NF-κB activation

Journal of Biological Chemistry

Volumn 288, Issue 22, 2013, Pages 15628-15640

  Huang, Xiao ^a,b   Gong, Ren ^a,c   Li, Xinyuan ^a   Virtue, Anthony ^a   Yang, Fan ^d   Yang, Irene H ^e   Tran, Anh H ^a   Yang, Xiao Feng ^a   Wang, Hong ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NANCHANG UNIVERSITY   (China)

^c Jiangxi Provincial People's Hospital   (China)

^d GRIFFIN HOSPITAL   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIO-VASCULAR DISEASE; CARDIO-VASCULAR DISEASE RISK FACTORS; CCAAT/ENHANCER-BINDING PROTEINS; EXPERIMENTAL DATABASE; EXPRESSED SEQUENCE TAGS; OXIDIZED PHOSPHOLIPIDS; PRO-INFLAMMATORY CYTOKINES; TRANSCRIPTIONAL REGULATION;

CYTOLOGY; DATABASE SYSTEMS; DISEASES; ENDOTHELIAL CELLS; GENES; HISTOLOGY; PHOSPHOLIPIDS; SEARCH ENGINES; SIGNALING; TISSUE; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

CCAAT ENHANCER BINDING PROTEIN; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; PHOSPHOLIPID;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA METHYLATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXPRESSED SEQUENCE TAG; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC DATABASE; HEART; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; LIPID OXIDATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; UNINDEXED SEQUENCE; VESSEL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE RISK FACTORS; CYTOKINE; GENE EXPRESSION; GENE EXPRESSION PROFILE; NF-KAPPAB; NF-KAPPAB ACTIVATION; PRETRANSLATIONAL MECHANISMS; PROINFLAMMATORY CYTOKINES; TRANSLATION;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MICE; NF-KAPPA B; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 84878398700     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.460626     Document Type: Article

References (29)

1. Baltimore, D. (2011) NF-κB is 25. Nat Immunol. 12, 683-685
2. Hayden, M. S., and Ghosh, S. (2008) Shared principles in NF-κB signaling. Cell 132, 344-362
3. Ghosh, S., and Hayden, M. S. (2008) New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8, 837-848
4. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62
5. Vallabhapurapu, S., and Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733
6. Yin, Y., Yan, Y., Jiang, X., Mai, J., Chen, N. C., Wang, H., and Yang, X. F. (2009) Inflammasomes are differentially expressed in cardiovascular and other tissues. Int. J. Immunopathol. Pharmacol. 22, 311-322
7. Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., Gutchigian, S., Frisch, A., Hodge, I., Jiang, X., Wang, H., and Yang, X. F. (2012) IL-35 is a novel responsive anti-inflammatory cytokine. A new system of categorizing anti-inflammatory cytokines. PLoS One 7, e33628
8. Ng, B., Yang, F., Huston, D. P., Yan, Y., Yang, Y., Xiong, Z., Peterson, L. E., Wang, H., and Yang, X. F. (2004) Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J. Allergy Clin. Immunol. 114, 1463-1470 (Pubitemid 39575906)
9. Virtue, A., Mai, J., Yin, Y., Meng, S., Tran, T., Jiang, X., Wang, H., and Yang, X. F. (2011) Structural evidence of anti-atherogenic microRNAs. Front Biosci. 16, 3133-3145
10. Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I., Gijbels, M. J., Kardakaris, R., Polykratis, A., Kollias, G., de Winther, M. P., and Pasparakis, M. (2008) Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab. 8, 372-383
11. Holloway, D. T., Kon, M., and DeLisi, C. (2005) Integrating genomic data to predict transcription factor binding. Genome Inform. 16, 83-94
12. Leeman, J. R., and Gilmore, T. D. (2008) Alternative splicing in the NF-κB signaling pathway. Gene 423, 97-107
13. Davuluri, R. V., Suzuki, Y., Sugano, S., Plass, C., and Huang, T. H. (2008) The functional consequences of alternative promoter use in mammalian genomes. Trends Genet. 24, 167-177
14. Su, Z., Wang, J., Yu, J., Huang, X., and Gu, X. (2006) Evolution of alternative splicing after gene duplication. Genome Res. 16, 182-189 (Pubitemid 43200266)
15. Thierry-Mieg, D., and Thierry-Mieg, J. (2006) AceView. A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 7, Suppl. 1, S12
16. Lopez-Pedrera, C., Pérez-Sánchez, C. Ramos-Casals, M., Santos-Gonzalez, M., Rodriguez-Ariza, A., and Cuadrado, M. J. (2012) Cardiovascular risk in systemic autoimmune diseases. Epigenetic mechanisms of immune regulatory functions. Clin. Dev. Immunol. 2012, 974648
17. Bartel, D. P. (2009) MicroRNAs. Target recognition and regulatory functions. Cell 136, 215-233
18. Zhang, C. (2008) MicroRNAs. Role in cardiovascular biology and disease. Clin. Sci. 114, 699-706
19. Naeem, H., Küffner, R., Csaba, G., and Zimmer, R. (2010) miRSel. Automated extraction of associations between microRNAs and genes from the biomedical literature. BMC Bioinformatics 11, 135
20. Sethupathy, P., Corda, B., and Hatzigeorgiou, A. G. (2006) TarBase. A comprehensive database of experimentally supported animal microRNA targets. RNA 12, 192-197 (Pubitemid 43121923)
21. Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Vera, M. P., MICU Registry, Blackwell, T. S., Baron, R. M., and Feinberg, M. W. (2012) MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J. Clin. Invest. 122, 1973-1990
22. Qi, J., Qiao, Y., Wang, P., Li, S., Zhao, W., and Gao, C. (2012) MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett. 586, 1201-1207
23. Kim, S. W., Ramasamy, K., Bouamar, H., Lin, A. P., Jiang, D., and Aguiar, R. C. (2012) MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor α-induced protein 3 (TNFAIP3, A20). Proc. Natl. Acad. Sci. U.S.A. 109, 7865-7870
24. Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato-Otsubo, A., Muto, S., Utsunomiya, A., Yamaguchi, K., Uchimaru, K., Ogawa, S., and Watanabe, T. (2012) Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell 21, 121-135
25. Takata, Y., Kitami, Y., Yang, Z. H., Nakamura, M., Okura, T., and Hiwada, K. (2002) Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-δ and peroxisome proliferator-activated receptor-γ. Circ. Res. 91, 427-433 (Pubitemid 35034211)
26. Modrek, B., and Lee, C. (2002)Agenomic view of alternative splicing. Nat. Genet. 30, 13-19
27. Maunakea, A. K., Chepelev, I., and Zhao, K. (2010) Epigenome mapping in normal and disease States. Circ. Res. 107, 327-339
28. Yang, F., Chen, I. H., Xiong, Z., Yan, Y., Wang, H., and Yang, X. F. (2006) Model of stimulation-responsive splicing and strategies in identification of immunogenic isoforms of tumor antigens and autoantigens. Clin. Immunol. 121, 121-133 (Pubitemid 44592577)
29. Yang, X. F., Yin, Y., and Wang, H. (2008) Vascular inflammation and Atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov. Today Ther. Strateg. 5, 125-142